English | Español
Patient Daily | Dec 8, 2025

Trial finds fixed-duration therapy as effective as continuous treatment for chronic lymphocytic leukemia
Patient Daily | Dec 8, 2025

Study finds intravenous iron improves survival for anemic patients hospitalized with bacterial infections
Patient Daily | Dec 8, 2025

Study shows no evidence of harm from using hydroxyurea during pregnancy
Patient Daily | Dec 8, 2025

FDA launches agency-wide deployment of agentic artificial intelligence
Patient Daily | Dec 8, 2025

Baylor College of Medicine hosts event reflecting on Hurricane Katrina's legacy
Patient Daily | Dec 8, 2025

Study finds disparities in AML diagnosis age and survival among Black and white patients
Patient Daily | Dec 8, 2025

Smartphone motion tests may help screen for early Parkinson’s-related dopamine loss
Patient Daily | Dec 8, 2025

Aza-ven combination outperforms standard induction chemo in new AML clinical trial

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'